Order Article Reprints

De Corso E, Mele DA, Rizzi A, Spanu C, Corbò M, Pisciottano S, Mastrapasqua RF, Baroni S, Porru DP, De Maio G, et al. Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study. Journal of Personalized Medicine. 2024; 14(9):1014. https://doi.org/10.3390/jpm14091014

De Corso, Eugenio, Dario Antonio Mele, Angela Rizzi, Camilla Spanu, Marco Corbò, Serena Pisciottano, Rodolfo Francesco Mastrapasqua, Silvia Baroni, Davide Paolo Porru, Gabriele De Maio, and et al. 2024. "Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study" Journal of Personalized Medicine 14, no. 9: 1014. https://doi.org/10.3390/jpm14091014

De Corso, E., Mele, D. A., Rizzi, A., Spanu, C., Corbò, M., Pisciottano, S., Mastrapasqua, R. F., Baroni, S., Porru, D. P., De Maio, G., Rizzuti, A., Di Bella, G. A., Ortolan, A., Bonini, M., Cefaloni, F., Boccabella, C., Lombardi, F., Chini, R., Caruso, C., ... Galli, J. (2024). Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study. Journal of Personalized Medicine, 14(9), 1014. https://doi.org/10.3390/jpm14091014